UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cyclic Administration of Pamidronate in Children with Severe Osteogenesis Imperfecta

The New England journal of medicine, 1998-10, Vol.339 (14), p.947-952

1998

Volltextzugriff (PDF)

Osteogenesis Imperfecta Types I, III, and IV: Effect of Pamidronate Therapy on Bone and Mineral Metabolism

The journal of clinical endocrinology and metabolism, 2003-03, Vol.88 (3), p.986-992

2003

Volltextzugriff (PDF)

Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry

Osteoporosis international, 2008-10, Vol.19 (10), p.1369-1378

2008

Volltextzugriff (PDF)

Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age

The journal of clinical endocrinology and metabolism, 2000-05, Vol.85 (5), p.1846-1850

2000

Volltextzugriff (PDF)

Graphic Medicine-The Best of 2019

JAMA : the journal of the American Medical Association, 2019-12, Vol.322 (24), p.2368

2019

Volltextzugriff (PDF)

The Gene Responsible for Pseudohypoparathyroidism Type Ib Is Paternally Imprinted and Maps in Four Unrelated Kindreds to Chromosome 20q13.3

Proceedings of the National Academy of Sciences - PNAS, 1998-09, Vol.95 (20), p.11798-11803

1998

Volltextzugriff (PDF)

Gender-Related Differences in the Relationship Between Densitometric Values of Whole-Body Bone Mineral Content and Lean Body Mass in Humans Between 2 and 87 Years of Age

Bone (New York, N.Y.), 1998-06, Vol.22 (6), p.683-690

1998

Volltextzugriff (PDF)

Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2013-10, Vol.382 (9902), p.1424-1432

2013

Volltextzugriff (PDF)

The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophy

Journal of bone and mineral research, 2010-03, Vol.25 (3), p.520-526

2010

Volltextzugriff (PDF)

Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans : Potential as an anabolic therapy for osteoporosis

The journal of clinical endocrinology and metabolism, 1998-08, Vol.83 (8), p.2786-2791

1998

Volltextzugriff (PDF)

Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone

The journal of clinical endocrinology and metabolism, 2003-10, Vol.88 (10), p.4569-4575

2003

Volltextzugriff (PDF)

Bone Mass, Size, and Density in Children and Adolescents With Osteogenesis Imperfecta: Effect of Intravenous Pamidronate Therapy

Journal of bone and mineral research, 2003-04, Vol.18 (4), p.610-614

2003

Volltextzugriff (PDF)

Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV

Pediatrics (Evanston), 2003-05, Vol.111 (5 Pt 1), p.1030-1036

2003

Volltextzugriff (PDF)

Type V Osteogenesis Imperfecta: A New Form of Brittle Bone Disease

Journal of bone and mineral research, 2000-09, Vol.15 (9), p.1650-1658

2000

Volltextzugriff (PDF)

Two Questions About Osteogenesis Imperfecta

Journal of pediatric orthopaedics, 2006-01, Vol.26 (1), p.148-149

Plotkin, Horacio

2006

Volltextzugriff (PDF)

Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta

Pediatrics (Evanston), 2003-05, Vol.111 (5 Pt 1), p.e601-e603

2003

Volltextzugriff (PDF)

Lumbar spine bone density in Argentine children

Calcified tissue international, 1996-03, Vol.58 (3), p.144-149

1996

Volltextzugriff (PDF)

Bone Healing in Children With Osteogenesis Imperfecta Treated With Bisphosphonates

Journal of pediatric orthopaedics, 2005-05, Vol.25 (3), p.332-335

2005

Volltextzugriff (PDF)

Bone Mineralization in Polyostotic Fibrous Dysplasia: Histomorphometric Analysis

Journal of bone and mineral research, 2002-11, Vol.17 (11), p.1949-1953

2002

Volltextzugriff (PDF)

Mineral density gain in vertebrae of osteoporotic women on oral pamidronate reverts a year after treatment discontinuance

Calcified tissue international, 1996-07, Vol.59 (1), p.70-72

1996

Volltextzugriff (PDF)

Bone mass in children: normative values for the 2-20-year-old population

Bone (New York, N.Y.), 1995-04, Vol.16 (4), p.393S-399S

1995

Volltextzugriff (PDF)

Effects of antimacrophage, antithymocyte, antilymphocyte and antispleen serum on the immune response in mice

Clinical and experimental immunology, 1970-10, Vol.7 (4), p.551-564

1970

Volltextzugriff (PDF)

Habituation in the neonatal rat

Developmental psychobiology, 1974-03, Vol.7 (2), p.121-127

1974

Volltextzugriff (PDF)

Serological Correlates of Protection against a GII.4 Norovirus

Clinical and vaccine immunology, 2015-08, Vol.22 (8), p.923-929

2015

Volltextzugriff (PDF)

Comparable bioavailability of two esophago-gastric protective formulations containing pamidronate. A cross-over trial in healthy young adults

Medicina (Buenos Aires), 2002, Vol.62 (4), p.317-322

2002

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(149)
Mit Volltextzugriff
(108)

Publikationsform

Artikel
(158)

Sprache

Englisch
(156)
Spanisch
(2)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Cyclic Administration of Pamidronate in Children with Severe Osteogenesis Imperfecta

Osteogenesis Imperfecta Types I, III, and IV: Effect of Pamidronate Therapy on Bone and Mineral Metabolism

Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry

Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age

Graphic Medicine-The Best of 2019

The Gene Responsible for Pseudohypoparathyroidism Type Ib Is Paternally Imprinted and Maps in Four Unrelated Kindreds to Chromosome 20q13.3

Gender-Related Differences in the Relationship Between Densitometric Values of Whole-Body Bone Mineral Content and Lean Body Mass in Humans Between 2 and 87 Years of Age

Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial

The relationship between fractures and DXA measures of BMD in the distal femur of children and adolescents with cerebral palsy or muscular dystrophy

Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans : Potential as an anabolic therapy for osteoporosis

Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone

Bone Mass, Size, and Density in Children and Adolescents With Osteogenesis Imperfecta: Effect of Intravenous Pamidronate Therapy

Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III, and IV

Type V Osteogenesis Imperfecta: A New Form of Brittle Bone Disease

Two Questions About Osteogenesis Imperfecta

Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta

Lumbar spine bone density in Argentine children

Bone Healing in Children With Osteogenesis Imperfecta Treated With Bisphosphonates

Bone Mineralization in Polyostotic Fibrous Dysplasia: Histomorphometric Analysis

Mineral density gain in vertebrae of osteoporotic women on oral pamidronate reverts a year after treatment discontinuance

Bone mass in children: normative values for the 2-20-year-old population

Effects of antimacrophage, antithymocyte, antilymphocyte and antispleen serum on the immune response in mice

Habituation in the neonatal rat

Serological Correlates of Protection against a GII.4 Norovirus

Comparable bioavailability of two esophago-gastric protective formulations containing pamidronate. A cross-over trial in healthy young adults

Aktive Filter

Suchergebnisse filtern